Acute myocardial infarction in a patient with metabolic syndrome (clinical case)

The article describes a clinical case of acute myocardial infarction (AMI) with ST segment elevation in a 60-year-old man with metabolic syndrome (MS). The patient has a long-term history of hypertension, impaired glucose tolerance and dyslipidemia, while the patient adhered to all recommended therapy. However, despite this, he periodically had chest pains, shortness of breath, and general weakness. In the spring of 2024, the cardio-pain syndrome lasted for 3 days, AMI developed, and a feeling of fear of death appeared. The patient's condition is on the background of thrombolytic therapy and direct stenting of the right coronary artery with positive dynamics. Subsequently, Cardiotone (a natural cardioprotector that strengthens the heart muscle by improving its oxygen supply, relieves inflammatory processes in the myocardium, and has antihypertensive, anti-ischemic, and cardiometabolic effects) was added to the previously recommended therapy. It is recommended for disorders of the cardiovascular system, as well as for increased physical exertion.

This clinical case demonstrates that the course of cardiovascular diseases associated with MS can very often and quickly become malignant, and even against the background of adequate therapy. After taking Cardiotone for more than a year, the studied patient has been feeling well in the post-infarction period, notes the absence of cardio-pain syndrome, normalization of blood pressure levels, and improvement in the quality of life in general. During the control routine coronary catheterization, the planned stenting of the obtuse edge branch was not required.